TECH BUYER Jul 2020 - IDC Perspective - Doc # EUR246718320

The New Impetus for Real-World Data in Life Sciences: COVID-19 and Beyond

By: Nino GiguashviliSenior Research Analyst

Abstract

This IDC Perspective analyzes the increasingly vital role of real-world data (RWD) in supporting life sciences efforts against COVID-19 pandemic, highlighting examples from life sciences companies operating in Europe and worldwide.

"The COVID-19 pandemic has signified the value of real-world data in life sciences to an unprecedented extent. This crisis gives remarkable momentum to life sciences companies' efforts to accelerate the use of RWD to support the generation of evidence critical for bringing new products to patients faster. Going forward, RWD will become an indispensable source of evidence to inform regulatory decisions on future diagnostics, vaccines, and treatments beyond public health emergencies" — Senior Research Analyst Nino Giguashvili, IDC Health Insights Europe.


Coverage

Content


Get More

When you purchase this document, the purchase price can be applied to the cost of an annual subscription, giving you access to more research for your investment.



Related Links

Do you have questions about this document
or available subscriptions?

Contact Us